Ran - OD
- Home
- Ran - OD
Ran - OD
- Proton pump inhibitors increase CKD risk by 52% in Diabetes patients’
- Long term PPI use commonly cause hypocalcaemia, hypomagnesaemia. arrhythmias, predisposition fractures, cramps and pneumonia’
- Oral supplement of magnesium and calcium were only partially effective while PPI treatment is maintained’
Magnesium2.3
- Magnesium citrate is more soluable and bio- available than magnesium oxide.
- Retards arterial calcification
- Events the develpement & aceleretation of arterial
atherosclerosis in CKD Patients
- Folic Acid
with methylcobalamin is an appropriate
adjunctive theraphy in CKD Patients.
- Protects against vascular calcification
- Stimulates vitamin K-dependent protein
- Inhibits of osteogenic factors
Restores altered mineral metabolism - Prevents vascular calcification
- Protective role in preventing arterial atherosclerosis
- RDA approved nutrients dosage
Indication
- In the prevention and amelioration of Vascular Calcification
- CKD patients
- Diabetic patients
- Patients with Atheroslerosis
- Ideal Magnesium maintenance
